"Reporting on Rapid Advancements of Clinical, Scientific and Business Developments in IO"
The 5th annual Immuno-Oncology (IO) 360° is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate. The three-day summit features 10 plenary sessions with over 80 speakers and includes ten plus hours of networking. There will be over 450 attendees representing pharma, biotechs, academia, research organizations, business development and the investment community focused on IO.
Timings07:30 AM - 06:30 PM (General)07:30 AM - 06:00 PM (General)
07:30 AM - 06:00 PM
(General)
1 more Timing | Entry FeesNot available** Check Official Website |
Participants500 Delegates60 ExhibitorsEstimated Count | Category & TypeConferenceMedical & Pharma Science & Research |
Editions26-28 Feb 2020 Interested06-08 Feb 2019 5th Edition 07-09 Feb 2018 4th Edition 01-03 Feb 2017 3rd Edition Frequency Annual | Official LinksWebsite ContactsReport Error Claim this event |
Event Reputation Organizer Reputation Based on 13 ratings Venue Reputation Venue to be announced | |
Organizer Send Stall Book RequestThe Conference Forum USARenowned | 22 events listed | |
Users Attending
Mark Wood
Vice President, Commercial Innovations at Crown CRO Helsinki, Finland
Redge Gonzales
Representative at Sales Cavite, Philippines
Shell Li
Assistant Vice President at Ali Las Vegas, United States
Mohamed Al Ameen
Pharmacist at Pfizer Baghdad, Iraq
Yaseen Gigani
Phd Scholar at Apeejay Stya University (asu) New Delhi, India
Christopher Lancaster
Director Business Development at Advanced Clinical Conshohocken, United States
Daniel karanu
Clinical nurse at Gertrude's children's hospital Nairobi, KenyaSpeakers (past edition)
Ronald Herbst
VP R&D, Head Oncology Research at MedImmun United States
Dave Messina
COO @ Cofactor Genomics, Y Combinator, Human Genome Project, RNA-based...
Cedrik M. Britten
Head Cellular Therapy - Immuno-oncology at GSK United Kingdom
Asthika Goonewardene
Senior Biotech Analyst @ Bloomberg Intelligence
Eric Rubin
SVP, Clinical Oncology at Merck
Kelie Luby
VP Clinical Trials Software- Mint Medical Hartford, United States
Anton Xavier
Assistant Director of Technology & Business Development at New...
Featured Hotels in New York
 | Deedee's Sky Rise Apartments at.. from USD 256 |
 | TRYP by Wyndham Newark Downtown from USD 118.15 |
 | Hotel Pennsylvania from USD 182 |
 | Sheraton Lincoln Harbor Hotel from USD 203.15 |
Mar 292019
Apr 022019